Abstract | OBJECTIVE: The aim of this study was to investigate the role of matrix metallopeptidase 12 (MMP-12) in the development of hepatocellular carcinoma (HCC). Materials and Methods: A total of 343 HCC patients were retrospectively analyzed. MMP-12 expression was detected by immunohistochemical staining and the correlation between MMP-12 expression and clinical features was analyzed. Serum interleukin-6 (IL-6) and IL-10 levels were detected by an enzyme-linked immunosorbent assay (ELISA). Survival analysis was performed using the Kaplan-Meier method and PD-L1 expression in T cells was detected by flow cytometry. Results: MMP-12 expression in HCC tissues showed no correlation with age, gender, viral infection, cirrhosis, Child-Pugh score, alpha-fetoprotein levels, or Barcelona-Clinic Liver Cancer stage. However, higher levels of MMP-12 expression were correlated with increased tumor size, poorer tumor cell differentiation, higher TNM stage, and poorer prognosis. Moreover, MMP-12 expression was positively correlated with PD-L1 expression. Further analysis indicated that the regulation of PD-L1 expression by MMP-12 may occur through the IL-6-signaling pathway. Conclusions: Higher levels of MMP-12 expression indicated a poorer prognosis. PD-L1 expression was positively correlated with MMP-12 expression, indicating that MMP-12 may promote the development of HCC through the up-regulation of PD-L1.
|
Authors | Hengjun Gao, Xu Zhou, Hongguang Li, Fangfeng Liu, Huaqiang Zhu, Xie Song, Zheyu Niu, Qingqiang Ni, Chuncheng Yang, Jun Lu |
Journal | Journal of investigative surgery : the official journal of the Academy of Surgical Research
(J Invest Surg)
Vol. 34
Issue 4
Pg. 366-372
(Apr 2021)
ISSN: 1521-0553 [Electronic] United States |
PMID | 31304819
(Publication Type: Journal Article)
|
Chemical References |
- MMP12 protein, human
- Matrix Metalloproteinase 12
|
Topics |
- Carcinoma, Hepatocellular
(enzymology)
- Humans
- Liver Neoplasms
- Matrix Metalloproteinase 12
- Prognosis
- Retrospective Studies
|